DDW News

Speaker Spotlight: AGA Presidential Plenary

[vc_row][vc_column][vc_column_text]

Session:

AGA Presidential Plenary

DDW Track:

Clinical Practice

Date and Time:

Friday, May 21, 10–11:30 a.m.

CME:

1.5 hours

Shahnaz Sultan, MD, MHSC

Session Description

Led by AGA Institute President Bishr Omary, MD, PhD, AGAF, the 2021 AGA Presidential Plenary is designed to highlight timely, high-impact research and recap AGA’s work this past year. The plenary will begin with the presidential address, “Pandemic Lessons Learned in Practice and Research,” and will include several keynote addresses.

Shahnaz Sultan, MD, MHSc, will present “Timely, Transparent and Trustworthy AGA Guidelines Highlight What We Know and Don’t Know.” Dr. Sultan is an associate professor of medicine and the program director for the Gastroenterology Fellowship Training Program at the University of Minnesota. She is a leader in guideline development and serves on the AGA Clinical Guidelines Committee and the GRADE Working Group.

Arun J. Sanyal, MD

After Dr. Sultan’s lecture, Arun J. Sanyal, MD, will give his presentation, “NAFLD or MAFLD: Names and Their Implications.” Dr. Sanyal will discuss the historical basis for NAFLD nomenclature and its deficiencies and the rationale for changing to MAFLD. He will also give a patient-centric review of what the change in nomenclature will mean and how secular trends in the field will be impacted by a name change. Dr. Sanyal is a professor of medicine, physiology and molecular pathology at Virginia Commonwealth University. He was recently ranked in the top 0.01% of medical scientists based on their impact on the field.

Mikael Dolsten, MD, PhD
Mikael Dolsten, MD, PhD

Following, Mikael Dolsten, MD, PhD, will present “The Making of the Pfizer-BioNTech COVID-19 Vaccine.” As Chief Scientific Officer at Pfizer Inc., Dr. Dolsten focuses on advancing Pfizer’s scientific breakthrough leadership in small-molecule medicine, biotherapeutics, gene therapies and vaccines. He also leads the Worldwide Research, Development and Medical organization at Pfizer.

Griffin P. Rodgers, MD
Griffin P. Rodgers, MD

In his presentation, “Post-Pandemic Path Forward for GI Research,” Griffin P. Rodgers, MD, director of the NIDDK, will present a brief overview of digestive disease research programs supported by the NIDDK. His presentation will feature research challenges and opportunities, including the COVID-19 pandemic, career development programs, the Institute’s strategic plan, and the inclusion of underrepresented minorities in the research enterprise.

During the session, Gail Hecht, MD, and Michael Camilleri, MD, will also be recognized as the 2020 and 2021 Friedenwald Medal recipients. The plenary will conclude with a live Q&A session so attendees can ask questions in real time.

SpeakerPresentation Title
Bishr Omary, MD, PhD, AGAFPandemic Lessons Learned in Practice and Research
Shahnaz Sultan, MD, MHScTimely, Transparent, and Trustworthy AGA Guidelines Highlight What We Know and Don’t Know
Arun Sanyal, MDNAFLD or MAFLD: Names and Their Implications
Mikael Dolsten, MD, PhDThe Making of the Pfizer-BioNTech COVID-19 Vaccine
Griffin P. Rodgers, MDPost-Pandemic Path Forward for GI Research
This session is included in the cost of registration for DDW 2021 and will be available to watch live or on demand until Aug. 23, 2021. Discounted registration rates are available through March 31. View the DDW Online Planner for the full DDW agenda over May 21-23.
[/vc_column_text][/vc_column][/vc_row]

One Response

  1. Looking forward to Enrich our CME ♡
    It’s my pleasured to cooperate with you all in my research on 《 NAFLD/ MAFLD Microbiome Signature 》♡
    Dr. M. Azzam Kayasseh
    Dr. Kayasseh Virtual Microbiome Innovation Centre
    Dr. Kayasseh Medical Clinic
    Dubai, UAE
    00971506538153

Leave a Reply

Your email address will not be published.